ArticleIn vivo (Athens, Greece)

Evaluation of Times-to-onset and Outcomes of Lung Adverse Events Associated With Sorafenib Using JADER.

Yuko Kanbayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.